The U.S. Supreme Court has put new limits on the availability of patents for diagnostic medical tests, ruling in favor of Mayo Clinic in their decision regarding the Mayo Collaborative Services vs. Prometheus case, that will shape the growing field of personalized health care. Finnegan partner Erika H. Arner said “The ruling was surprising and a “real departure” from past Supreme Court cases. The Court’s focus on laws of nature means the ruling will have a bigger impact on the biotechnology industry than computer companies.” Additionally, she stated “The Court was careful, it seems, to avoid any unintended consequences.”
Media Mention
Finnegan Shortlisted for the 2024 Asian Legal Business Japan Law Awards
April 26, 2024
Commentary
April 11, 2024
Media Mention
Women in Business Law Americas Awards 2024: Three Finnegan Attorneys Shortlisted
April 7, 2024
Press Release
Finnegan and BMW Group Successfully Demolish Non-Practicing Entity NorthStar’s Efforts
April 3, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.